The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions

• Published in: European neuropsychopharmacology Vol. 73; pp. 24 - 35
• Main Authors: Gimbach, Sophie, Vogel, Daniel, Fried, Roland, Faraone, Stephen V., Banaschewski, Tobias, Buitelaar, Jan, Döpfner, Manfred, Ammer, Richard
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2023; Published by Elsevier B.V
• Subjects: ADHD; COVID-19 pandemic; Defined daily dose; Oxford stringency index; Pharmacoepidemiology; Time series forecasting; Oxford stringency index; Pharmacoepidemiology; Time series forecasting; ADHD; COVID-19 pandemic; Defined daily dose

•The global ADHD medication consumption increased from 2019 to 2020 only by 0.69%.•In 2020, the mean consumption per country was on average 6.2% lower than forecasted.•In 2021, the usage levels exceeded the pre-pandemic forecasts by 1.60% on average.•High correlation between consumption drop and str...